BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 34193202)

  • 1. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
    Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
    J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction.
    Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B
    Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer.
    Zhou L; Yu Y; Wen R; Zheng K; Jiang S; Zhu X; Sui J; Gong H; Lou Z; Hao L; Yu G; Zhang W
    Front Oncol; 2022; 12():863094. PubMed ID: 35619909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a New Ferroptosis-related Prognosis Model for Survival Prediction in Colorectal Cancer.
    Chen L; Ge M; Mo S; Shi M; Zhang J; Liu J
    Curr Med Chem; 2024 Feb; ():. PubMed ID: 38362684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cuproptosis-related subtypes and development of a prognostic signature in colorectal cancer.
    Huang Y; Yin D; Wu L
    Sci Rep; 2022 Oct; 12(1):17348. PubMed ID: 36253436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma.
    Yang C; Huang S; Cao F; Zheng Y
    BMC Cancer; 2021 Nov; 21(1):1182. PubMed ID: 34740325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of macrophage-related molecular subgroups and risk signature in colorectal cancer based on a bioinformatics analysis.
    Liu Q; Liao L
    Autoimmunity; 2024 Dec; 57(1):2321908. PubMed ID: 38466182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
    Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M
    Front Immunol; 2023; 14():1279789. PubMed ID: 37928532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
    Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
    Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer.
    Liu J; Yu F; Liu Z; Wang X; Li J
    Cancer Biother Radiopharm; 2022 Dec; 37(10):963-975. PubMed ID: 34551265
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of a Novel Lipid Metabolism-related Gene Prognostic Signature for Patients with Colorectal Cancer.
    Zhan J; Cen W; Zhu J; Ye Y
    Recent Pat Anticancer Drug Discov; 2024; 19(2):209-222. PubMed ID: 37723964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel lipid metabolism-related gene signature for predicting colorectal cancer survival.
    Huang Y; Zhou J; Zhong H; Xie N; Zhang FR; Zhang Z
    Front Genet; 2022; 13():989327. PubMed ID: 36147494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
    Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
    PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Gene Expression Profiles Identifies a
    Chen Z; Chen M; Xue Z; Zhu X
    Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of a hypoxia-related gene prognostic signature in colorectal cancer based on bulk and single-cell RNA-seq.
    Qiao Y; Jiang X; Li Y; Wang K; Chen R; Liu J; Du Y; Sun L; Li J
    Sci Rep; 2023 Feb; 13(1):2503. PubMed ID: 36781976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
    Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
    J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
    Wu B; Tao L; Yang D; Li W; Xu H; He Q
    Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.